The new pill, called AD109, is a combination of atomoxetine and aroxybutynin, two drugs that tell your brain to keep the ...

An estimated 30 million Americans have sleep apnea, which is defined as recurring episodes of partial or complete airway ...

SecondwindCPAP, a leading provider of high-quality new and refurbished CPAP and BiPAP machines, today announced its enhanced focus on travel-ready CPAP solutions, empowering individuals with sleep ...

Long Islanders suffering from sleep apnea inundated the sleep center at St. Charles Hospital in Port Jefferson with phone ...

Apnimed's experimental drug reduced breathing interruptions by nearly 46.8% in clinical trials, offering a potential ...

The first oral pill for obstructive sleep apnea could be around the corner after company Apnimed reported positive results ...

Pharmaceutical company Apnimed says it's getting positive results from the clinical trials for an oral pill that could treat ...

In today’s Health Alert, obstructive sleep apnea may soon be treated with a simple, once-a-day pill. This first-in-class oral ...

The Sleep Apnea Devices Market presents robust growth opportunities, especially in regions like North America and Europe where awareness, infrastructure, and reimbursement support are strong. However, ...

Resmed beat Wall Street estimates for fourth-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea. The company makes continuous positive airway pressure (CPAP ...

While snoring is common and usually harmless, sometimes it can be sign of sleep apnea. Here's how you can differentiate ...

Obstructive sleep apnea is still largely undiagnosed and untreated. In a growing marketplace of solutions, can negative pressure devices compete?